Fang Zhang

ORCID: 0000-0001-7032-683X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Health Systems, Economic Evaluations, Quality of Life
  • Healthcare Policy and Management
  • Energy, Environment, Economic Growth
  • Economic and Financial Impacts of Cancer
  • Market Dynamics and Volatility
  • Medication Adherence and Compliance
  • Atmospheric and Environmental Gas Dynamics
  • Climate Change Policy and Economics
  • Artificial Intelligence in Healthcare
  • Primary Care and Health Outcomes
  • Energy, Environment, and Transportation Policies
  • Topic Modeling
  • Advanced Text Analysis Techniques
  • Big Data and Business Intelligence
  • Digital Marketing and Social Media
  • Pharmaceutical Economics and Policy
  • Recommender Systems and Techniques
  • Global Cancer Incidence and Screening
  • Private Equity and Venture Capital
  • Advanced Bandit Algorithms Research
  • Pharmaceutical Practices and Patient Outcomes

Capital University of Economics and Business
2020-2023

Harvard Pilgrim Health Care
2006-2022

Harvard University
2006-2022

Wuhan University
2022

Tsinghua University
2022

Zhongnan Hospital of Wuhan University
2022

Dana-Farber Cancer Institute
2018

Ontario Institute for Cancer Research
2018

Abt Global (United States)
2009

University of Massachusetts Chan Medical School
2009

Purpose High-deductible health plans (HDHPs) require substantial out-of-pocket spending and might delay crucial services. Breast cancer treatment delays of as little 2 months are associated with adverse outcomes. Methods We used a controlled prepost design survival analysis to assess timing breast care events among 273,499 women age 25 64 years without evidence before inclusion. Women were included if continuously enrolled for 1 year in low-deductible ($0 $500) plan followed by up 4 HDHP (at...

10.1200/jco.2017.75.2501 article EN Journal of Clinical Oncology 2018-02-28

10.1007/s11356-022-19713-x article EN Environmental Science and Pollution Research 2022-03-19

Background: Prior authorization is a popular, but understudied, strategy for reducing medication costs.We evaluated the impact of controversial prior policy in Michigan Medicaid on antidepressant use and health outcomes among dual Medicare enrollees with Social Security Disability Insurance designation permanent disability.Methods: We linked (2000-2003) claims comparison state, Indiana.Using interrupted time-series longitudinal data analysis, we estimated use, treatment initiation,...

10.1001/archinternmed.2009.39 article EN Archives of Internal Medicine 2009-04-27

Objective. To examine whether high-deductible health plans (HDHPs) that exempt prescription drugs from full cost sharing preserve medication use for major chronic illness, compared with traditional HMOs similar drug sharing. Data Sources/Study Setting. We examined 2001–2008 pharmacy claims data of 3,348 continuously enrolled adults in a Massachusetts plan 9 months before and 24 after an employer-mandated switch HMO to HDHP, 20,534 contemporaneous matched members. Both study groups faced...

10.1111/j.1475-6773.2011.01252.x article EN Health Services Research 2011-03-17

State Medicaid programs introduce many types of prescribing restrictions to manage pharmaceutical use and expenditure. Little is known about the differential effect implementing prior authorization (PA) policies at market entry versus waiting until several years later when behavior may already be established.We sought examine impact on overall Cox II inhibitors PA implemented least 2 after entry.We quantified inhibitor nonselective nonsteroidal anti-inflammatory drug (NSAID) utilization for...

10.1097/01.mlr.0000204056.31664.36 article EN Medical Care 2006-03-16

Emission trading scheme (ETS), the most popular market-based instrument, is widely used to solve carbon emission problems in world. With development of market, asset has been a financial product invest and risk management becomes important for government, regulated enterprises other investors. As prices have tail characteristics, this paper explores extremal risks between markets US, Europe China using dependence correlation coefficients. The empirical analysis demonstrates structure US....

10.1371/journal.pone.0238033 article EN cc-by PLoS ONE 2020-08-28

Users' historical activities are usually contained in real-life sequential recommendation systems to predict their future behaviors. In this situation, traditional Factorization Machines (FMs) approaches may be not suitable. Recently, a new surge of interest aims use recurrent neural networks(RNN) encode users' dynamic features with temporal characteristics. However, most these works fail reproduce computational simplicity FMs. paper, we propose an architecture extended-FM for...

10.1109/access.2020.2977231 article EN cc-by IEEE Access 2020-01-01

552 Background: High-deductible health plans (HDHPs) requiring substantial out-of-pocket costs for most services might reduce appropriate care. This study examined the impact of modern HDHPs on use adjuvant hormonal therapy, which is a fundamental treatment secondary prevention in patients with breast cancer. Methods: We studied 970 women newly diagnosed early cancer who were insured by employers that mandated transition from low-deductible ( < = $500) to high deductible > $1,000) coverage...

10.1200/jco.2016.34.15_suppl.552 article EN Journal of Clinical Oncology 2016-05-20

6503 Background: High-deductible health plans (HDHPs) have grown rapidly in recent years, and now cover over one-half of U.S. workers. Patients HDHPs are liable for the costs all cancer-related care until their annual deductible is met, with exception screening tests such as colonoscopy mammography. Due to increased out-of-pocket obligations, patients may postpone presenting concerning symptoms or diagnostic testing, leading delayed diagnosis. We therefore assessed impacts on timing...

10.1200/jco.2022.40.16_suppl.6503 article EN Journal of Clinical Oncology 2022-06-01

In recent years, the continuous development of big data, cloud services, Internet+, artificial intelligence, and other technologies has accelerated improvement data communication services in traditional pharmaceutical industry. It plays a leading role my country’s industry, deepening reform health system, improving efficiency quality medical developing new technologies. this context, we make following research draw conclusions: (1) scale market is constantly increasing, global also...

10.1155/2022/4224287 article EN Computational and Mathematical Methods in Medicine 2022-09-09
Coming Soon ...